Education
About Us
Working with TipRanks
Follow Us
Medpace Holdings (MEDP)
NASDAQ:MEDP
Total Valuation
Medpace Holdings has a market cap or net worth of $12.66B. The enterprise value is $12.63B.
Market Cap$12.66B
Enterprise Value$12.63B
Share Statistics
Medpace Holdings has 28,381,283 shares outstanding. The number of shares has decreased by -2.65% in one year.
Shares Outstanding28,381,283
Owned by Insiders19.39%
Owned by Institutions18.48%
Financial Efficiency
Medpace Holdings’s return on equity (ROE) is 0.98 and return on invested capital (ROIC) is 67.94%.
Return on Equity (ROE)0.98
Return on Assets (ROA)0.23
Return on Invested Capital (ROIC)67.94%
Return on Capital Employed (ROCE)0.85
Revenue Per Employee428.85K
Profits Per Employee76.46K
Employee Count5,900
Asset Turnover1.28
Inventory Turnover0.00
Valuation Ratios
The current PE Ratio of Medpace Holdings is 29.2. Medpace Holdings’s PEG ratio is 1.82.
PE Ratio29.2
PS Ratio6.40
PB Ratio35.29
Price to Fair Value35.29
Price to FCF23.76
Price to Operating Cash Flow18.00
PEG Ratio1.82
Income Statement
In the last 12 months, Medpace Holdings had revenue of 2.53B and earned 451.12M in profits. Earnings per share was 15.64.
Revenue2.53B
Gross Profit760.62M
Operating Income534.93M
Pretax Income542.38M
Net Income451.12M
EBITDA570.50M
Earnings Per Share (EPS)15.64
Cash Flow
In the last 12 months, operating cash flow was 713.22M and capital expenditures -4.54M, giving a free cash flow of 708.69M billion.
Operating Cash Flow713.22M
Free Cash Flow708.69M
Free Cash Flow per Share24.97
Dividends & Yields
Medpace Holdings pays an annual dividend of ―, resulting in a dividend yield of ―
Dividend Per Share―
Dividend Yield―
Payout RatioN/A
Free Cash Flow Yield―
Earnings Yield―
Stock Price Statistics
Beta1.24
52-Week Price Change31.78%
50-Day Moving Average557.14
200-Day Moving Average472.96
Relative Strength Index (RSI)30.81
Average Volume (3m)363.91K
Important Dates
Medpace Holdings upcoming earnings date is Apr 27, 2026, After Close (Confirmed).
Last Earnings DateFeb 9, 2026
Next Earnings DateApr 27, 2026
Ex-Dividend Date―
Financial Position
Medpace Holdings as a current ratio of 0.74, with Debt / Equity ratio of 54.57%
Current Ratio0.74
Quick Ratio0.74
Debt to Market Cap<0.01
Net Debt to EBITDA-0.43
Interest Coverage Ratio0.00
Taxes
In the past 12 months, Medpace Holdings has paid 91.25M in taxes.
Income Tax91.25M
Effective Tax Rate0.17
Enterprise Valuation
Medpace Holdings EV to EBITDA ratio is 27.97, with an EV/FCF ratio of 23.40.
EV to Sales6.31
EV to EBITDA27.97
EV to Free Cash Flow23.40
EV to Operating Cash Flow22.37
Balance Sheet
Medpace Holdings has $497.05M in cash and marketable securities with $250.50M in debt, giving a net cash position of $246.55M billion.
Cash & Marketable Securities$497.05M
Total Debt$250.50M
Net Cash$246.55M
Net Cash Per Share$8.69
Tangible Book Value Per Share-$8.21
Margins
Gross margin is 30.06%, with operating margin of 21.14%, and net profit margin of 17.83%.
Gross Margin30.06%
Operating Margin21.14%
Pretax Margin21.44%
Net Profit Margin17.83%
EBITDA Margin22.55%
EBIT Margin21.44%
Analyst Forecast
The average price target for Medpace Holdings is $521.29, which is 11.43% higher than the current price. The consensus rating is Moderate Buy
Price Target$521.29
Price Target Upside14.88% Upside
Analyst ConsensusModerate Buy
Analyst Count7
Revenue Growth Forecast13.88%
EPS Growth Forecast23.92%